138 related articles for article (PubMed ID: 17543084)
1. Expression of the UV-induced molecule, Gadd45, in atypical fibroxanthoma.
Sakamoto A; Oda Y; Tsuneyoshi M; Iwamoto Y
Histopathology; 2007 Jun; 50(7):939-41. PubMed ID: 17543084
[No Abstract] [Full Text] [Related]
2. Hyalin perivascular arcs and rings in sclerosing atypical fibroxanthomas.
Lehmer LM; Ragsdale BD
Am J Dermatopathol; 2012 Feb; 34(1):124-6. PubMed ID: 22193281
[No Abstract] [Full Text] [Related]
3. Granular cell atypical fibroxanthoma: case report and review of the literature.
Wright NA; Thomas CG; Calame A; Cockerell CJ
J Cutan Pathol; 2010 Mar; 37(3):380-5. PubMed ID: 19341433
[TBL] [Abstract][Full Text] [Related]
4. Calponin and h-caldesmon expression in atypical fibroxanthoma and superficial leiomyosarcoma.
Sakamoto A; Oda Y; Yamamoto H; Oshiro Y; Miyajima K; Itakura E; Tamiya S; Honda Y; Ishihara A; Iwamoto Y; Tsuneyoshi M
Virchows Arch; 2002 Apr; 440(4):404-9. PubMed ID: 11956822
[TBL] [Abstract][Full Text] [Related]
5. Two brief reviews of recent articles in the American Journal of Surgical Pathology.
Winfield HL; Chang TT
J Cutan Pathol; 2009 Apr; 36(4):499-501. PubMed ID: 19278441
[No Abstract] [Full Text] [Related]
6. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
7. Atypical fibroxanthoma and malignant fibrous histiocytoma.
Bell D
Am J Dermatopathol; 1979; 1(2):185. PubMed ID: 232973
[No Abstract] [Full Text] [Related]
8. Morphological and immunohistochemical characteristics of atypical fibroxanthoma with a special emphasis on potential diagnostic pitfalls: a review.
Luzar B; Calonje E
J Cutan Pathol; 2010 Mar; 37(3):301-9. PubMed ID: 19807823
[TBL] [Abstract][Full Text] [Related]
9. Atypical fibroxanthoma and malignant fibrous histiocytoma of the skin.
Rizzardi C; Angiero F; Melato M
Anticancer Res; 2003; 23(2C):1847-51. PubMed ID: 12820468
[TBL] [Abstract][Full Text] [Related]
10. More than 2 decades of treating atypical fibroxanthoma at mayo clinic: what have we learned from 91 patients?
Ang GC; Roenigk RK; Otley CC; Kim Phillips P; Weaver AL
Dermatol Surg; 2009 May; 35(5):765-72. PubMed ID: 19389106
[TBL] [Abstract][Full Text] [Related]
11. CD117 immunoreactivity in atypical fibroxanthoma.
Mathew RA; Schlauder SM; Calder KB; Morgan MB
Am J Dermatopathol; 2008 Feb; 30(1):34-6. PubMed ID: 18212542
[TBL] [Abstract][Full Text] [Related]
12. HMB-45 expression in a clear cell variant of atypical fibroxanthoma.
Cai JP; Randall B
J Cutan Pathol; 2006 Feb; 33(2):186-8. PubMed ID: 16420318
[No Abstract] [Full Text] [Related]
13. Mutation analysis of the Gadd45 gene at exon 4 in atypical fibroxanthoma.
Sakamoto A; Akieda S; Oda Y; Iwamoto Y; Tsuneyoshi M
BMC Dermatol; 2009 Jan; 9():1. PubMed ID: 19128509
[TBL] [Abstract][Full Text] [Related]
14. [Fibrohistiocytic tumor of skin].
Wang J
Zhonghua Bing Li Xue Za Zhi; 2013 Feb; 42(2):134-7. PubMed ID: 23710926
[No Abstract] [Full Text] [Related]
15. Granular cell atypical fibroxanthoma.
Rudisaile SN; Hurt MA; Santa Cruz DJ
J Cutan Pathol; 2005 Apr; 32(4):314-7. PubMed ID: 15769283
[TBL] [Abstract][Full Text] [Related]
16. Atypical fibroxanthoma of the head and neck: report of 5 cases.
González-García R; Nam-Cha SH; Muñoz-Guerra MF; Sastre-Pérez J; Rodríguez-Campo FJ; Naval-Gías L
J Oral Maxillofac Surg; 2007 Mar; 65(3):526-31. PubMed ID: 17307603
[No Abstract] [Full Text] [Related]
17. Atypical fibroxanthoma showing diffuse staining for CD31.
Aliste C; Suarez Peñaranda JM
J Cutan Pathol; 2011 Aug; 38(8):679-80. PubMed ID: 21518383
[No Abstract] [Full Text] [Related]
18. Ribosomal protein S27-like, a p53-inducible modulator of cell fate in response to genotoxic stress.
Li J; Tan J; Zhuang L; Banerjee B; Yang X; Chau JF; Lee PL; Hande MP; Li B; Yu Q
Cancer Res; 2007 Dec; 67(23):11317-26. PubMed ID: 18056458
[TBL] [Abstract][Full Text] [Related]
19. The origin of osteoclast-like giant cells in atypical fibroxanthoma.
Orlandi A; Bianchi L; Ferlosio A; Innocenzi I; Spagnoli LG
Histopathology; 2003 Apr; 42(4):407-10. PubMed ID: 12653956
[No Abstract] [Full Text] [Related]
20. h-caldesmon immunoreactivity in atypical fibroxanthoma: implications for the differential diagnosis.
Martinez-Ciarpaglini C; Agustí J; Alvarez E; Hueso L; Terrádez L; Monteagudo C
Pathology; 2018 Apr; 50(3):358-361. PubMed ID: 29490873
[No Abstract] [Full Text] [Related]
[Next] [New Search]
